Randomized Trial: Proton Pump Inhibitor Not Effective for Prevention of Gastroduodenal Events in Patients Receiving Low-dose Anticoagulation and/or Aspirin 26 Jul, 2019 | 00:44h | UTC Pantoprazole to Prevent Gastroduodenal Events in Patients Receiving Rivaroxaban and/or Aspirin in a Randomized, Double-Blind, Placebo-Controlled Trial – Gastroenterology (free)